Amarin Corp Plc (AMRN)

[HDGabor]

m-

it seems weird. more scripts we get, the ratio gets higher?

Because it is not a ratio … Sam's number is $ based on Symphony (V dispensed to patients) meanwhile the other $ is Net Revenue (V sold to WSs)

I said it could be higher than Q4 but won't be surprised by less than $70/75M … but it was before I understand the weekly script report (special thanks to raf- for the clarification).

I am little bit more optimistic now, as "could be higher than Q4 but won't be surprised by less than $75M" since the pill# increased significantly (app. 540 vs 630 in Q4 vs Q1).

Best,
G